Treatment Strategies for Metastatic Non–Small-Cell Lung Cancer
- 1 August 1999
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 1 (1) , 34-41
- https://doi.org/10.3816/clc.1999.n.001
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Perceptions of Prognosis, Treatment, and Treatment Impact on Prognosis in Non-small Cell Lung CancerChest, 1998
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1991
- Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancerCancer, 1991
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancerBritish Journal of Cancer, 1990
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?Cancer, 1989
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986